Punjab Covid-19 death rate India’s worst

CHANDIGARH: After recording 71 fresh Covid-19 deaths on Wednesday, Punjab fatality rate went up to 2.95%, surpassing Maharashtra’s mortality rate of 2.90%.
With 2,061 people out of 69,684 infected succumbing to the virus, Punjab now has the highest mortality rate in the country. Since August 1, 1,675 people have lost their lives, 41.8 deaths in a day on an average.
There is no relief from the trend in sight as 74 people in critical condition are on ventilator support while 573 are on oxygen support. Punjab has a low survival rate of infected patients intubated on ventilators till now.
Of 71 deaths reported in the last 24 hours, 13 people lost their lives in Ludhiana, 11 in Amritsar, eight in Patiala, six in Kapurthala, five each in Sangrur and Bathinda. Four deaths each were reported in Hoshiarpur, Fatehgarh Sahib and Nawanshahr, three in Amritsar, two in Gurdaspur and one each in Ropar, Pathankot, Mansa, Ferozepur and Fazilka.
Punjab posted yet another single-day highest count of cases as 2,137 people were tested positive. Of fresh cases, the highest of 319 were reported in Mohali, 311 in Amritsar, 240 in Ludhiana, 210 in Jalandhar, 173 in Gurdaspur, 159 in Patiala, 130 in Bathinda, 94 in Hoshiarpur, 57 in Sangrur, 54 in Faridkot, 53 in Muktsar, 52 in Fazilka, 49 in Ferozepur, 45 in Kapurthala, 37 in Moga, 35 in Tarn Taran, 31 in Mansa, 24 in Nawanshahr, 22 in Fatehgarh Sahib, 19 in Pathankot and 15 in Barnala.
As 1,231 people were discharged after recovery, the tally of patients discharged now stands at 50,558. Of these, 314 were discharged in Ludhiana, 160 in Jalandhar, 131 in Amritsar, 128 in Patiala, 113 in Bathinda, 64 in Moga, 53 in Gurdaspur, 37 in Muktsar, 35 in Faridkot, 32 in Fazilka, 27 in Kapurthala, 24 in Hoshiarpur, 23 in Ropar, 20 each in Barnala and Fatehgarh Sahib, 15 in Nawanshahr, 11 in Pathankot, and two in Tarn Taran.
In a meeting between the CM and Congress MLAs, health secretary Hussan Lal said 90% deaths in Punjab had been reported among Level III patients, 7.6% among Level II and the remaining among patients in home isolation.